CLX Investment Company, Inc. (OTCBB: CLXN) today announced that portfolio investment Zonda Incorporated, which specializes in diagnostic tests that serve the medical, bacterial food safety, cosmetic, beverage, pharmaceutical, veterinary, and environmental sanitation testing markets, has opened new global markets for its products with a distribution agreement for its HandiLab-C chlamydia test in Australia and New Zealand.
